Health care stocks advanced pre-bell Friday with the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) 0.2% higher recently.
Applied Therapeutics (APLT) said late Wednesday that the US Food and Drug Administration issued a complete response letter indicating the health regulator's decision not to approve the new drug application for govorestat to treat classic galactosemia due to "deficiencies in the clinical application." Applied Therapeutics shares tumbled by over 74% premarket.
RadNet's (RDNT) shares were almost 4% higher after its DeepHealth unit said it received expanded US Food and Drug Administration 510(k) clearance for its SmartMammo mammography software.
TC BioPharm (TCBP) shares were down 12% after the company filed a registration statement with the US Securities and Exchange Commission Wednesday for the potential sale of up to $100 million of securities from time to time in one or more offerings.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.